Ignite Creation Date:
2024-05-06 @ 2:00 PM
Last Modification Date:
2024-10-26 @ 1:23 PM
Study NCT ID:
NCT04182724
Status:
UNKNOWN
Last Update Posted:
2019-12-03
First Post:
2019-11-27
Brief Title:
Camrelizumab Apatinib and Nab-paclitaxel as Second-line Treatment in Advanced Gastric Cancer
Sponsor:
Chinese PLA General Hospital
Organization:
Chinese PLA General Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-11-12
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-05-12
Completion Date Type:
ESTIMATED
First Submit Date:
2019-11-27
First Submit QC Date:
November 27 2019
Study First Post Date:
2019-12-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-01
Last Update Post Date:
2019-12-03
Last Update Post Date Type:
ACTUAL